Brief: Index Pharmaceuticals Q2 Operating Loss Narrows To SEK 17.7 Million

Flerie AB

15/08/2019 07:26

Aug 15 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * (PUBL) INTERIM REPORT JANUARY - JUNE 2019
    * Q2 OPERATING LOSS SEK 17.7 MILLION VERSUS LOSS SEK 26.0
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkrXvhSM 
Further company coverage:  INDEX.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))